CRISPR Therapeutics AG (CRSP)
51.48
-0.12
(-0.23%)
USD |
NASDAQ |
Jun 09, 16:00
51.07
-0.41
(-0.80%)
After-Hours: 20:00
CRISPR Therapeutics SG&A Expense (Quarterly) : 17.18M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 493.70M |
| BeOne Medicines Ltd. | 556.75M |
| AC Immune SA | 5.326M |
| Idorsia Ltd. | 77.58M |
| ADC Therapeutics SA | 22.60M |